FER vs OMAB Stock Comparison

Ferrovial and Central North Airport Prices as of Oct 26, 2026 Peers: Industry group
FER Ferrovial N.V.
$50.35 -9.8% 1M -21.8% 1Y
Market cap
$36.28B
P/E
36.1x
Revenue (TTM)
—
Div. yield
2.57%
Engineering and Construction Industrials
2 wins

Head to Head

7 decided of 12

Central North Airport leads on 5 of the 12 questions below (Central North Airport 5, Ferrovial 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionFEROMABLeader
Larger companyMarket capitalisation $36.28B $4.78B FER
Cheaper on earningsLower P/E, profitable companies only 36.1x 16.1x OMAB
Cheaper on forward earningsLower price / next fiscal year consensus EPS 46.2x 14.8x OMAB
Faster revenue growthRevenue growth, trailing twelve months — — –
More profitableNet margin, trailing twelve months — — –
Better return on capitalReturn on invested capital — — –
Less leveragedLower net debt / EBITDA — — –
Higher dividend yieldTrailing dividend yield 2.57% 5.47% OMAB
Better 1-year returnPrice return, last 12 months -21.8% -3.6% OMAB
Better 5-year returnAnnualised price return, 5 years +11.4%/yr +15.2%/yr OMAB
Less volatileAnnualised volatility, 1 year 25.4% 31.2% FER
Higher overall scoreMean of the five percentile scores vs peers — 34/100 –

Percentile Scorecard

FEROMAB

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisFEROMAB
Valuation 62 #9 of 22 17 #68 of 82
Growth – –
Profitability – –
Financial Health 35 #18 of 27 28 #66 of 91
Shareholder Returns – 56 #19 of 42
Overall – 34
  • FER ranked among 27 companies in Construction Services
  • OMAB ranked among 93 companies in Transportation

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodFEROMABSPY
1 month -9.8%-3.9% -0.8%
3 months -19.9%-5.5% +3.5%
6 months -25.6%-10.9% +7.0%
Year to date -22.1%-9.0% +12.2%
1 year -21.8%-3.6% +13.0%
3 years +54.9%+74.4% +86.3%
3 years, per year +15.7%+20.4% +23.1%
5 years +71.3%+102.8% +68.6%
5 years, per year +11.4%+15.2% +11.0%
10 years +137.7%+104.2% +258.0%
10 years, per year +9.0%+7.4% +13.6%

Risk

MeasureFEROMABSPY
Volatility, 1Y 25.4%31.2% 12.7%
Downside volatility, 1Y 24.6%28.1% 12.7%
Beta vs S&P 500, 1Y 1.021.12 1.00
Return / volatility, 1Y -0.86-0.12 1.02
Max drawdown, 5Y -34.3%-42.1% -25.4%
From 52-week high -32.3%-26.7% -1.8%
52-week high $74.38$134.98 $779.14
52-week low $48.86$88.75 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleFEROMAB
P/E now vs peer median 36.1xmedian 36.1x 16.1xmedian 10.7x
P/S now vs peer median 3.3xmedian 1.0x 5.4xmedian 1.2x
EV/EBITDA now vs peer median —median 5.8x —median 6.6x
P/FCF now vs peer median 18.5xmedian 18.5x 11.8xmedian 7.1x
P/B now vs peer median 5.2xmedian 1.7x 7.5xmedian 0.9x
PEG now vs peer median —median 1.34 —median 0.68

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsFEROMAB
Cash & equivalents $5.02B $172.32M
Total debt $12.25B $1.84B
Shares (diluted) 718.72M –
Enterprise value $16.60B $4.27B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricFEROMAB
P/E 36.1x 16.1x
P/FCF 18.5x 11.8x
P/Operating cash flow – –
P/S 3.3x 5.4x
P/B 5.2x 7.5x
P/Tangible book 5.3x -9.6x
EV/EBITDA – –
EV/EBIT – –
EV/Revenue – –
EV/FCF – –
EV/Operating cash flow – –
PEG (3Y EPS CAGR) – –

Growth

14 metrics
MetricFEROMAB
Revenue growth (1Y) – –
Revenue CAGR (3Y) – –
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) – –
Operating income CAGR (3Y) – –
Net income growth (1Y) – –
Net income CAGR (3Y) – –
EPS growth (1Y) – –
EPS CAGR (3Y) – –
Operating cash flow growth (1Y) – –
Operating cash flow CAGR (3Y) – –
Free cash flow growth (1Y) – –
Free cash flow CAGR (3Y) – –

Profitability

14 metrics
MetricFEROMAB
Gross margin – –
EBITDA margin – –
Operating margin – –
Pretax margin – –
Net margin – –
FCF margin – –
Operating cash flow margin – –
Return on equity – –
Return on assets – –
Return on invested capital – –
Return on capital employed – –
Asset turnover – –
Cash conversion (OCF / net income) – –
Stock comp / revenue – –

Financial Health

11 metrics
MetricFEROMAB
Debt / assets 38.0% 43.4%
Debt / equity 1.8x 1.2x
Net debt / EBITDA – –
Debt / FCF – –
Liabilities / assets 78.5% 63.1%
Equity / assets 21.5% 36.9%
Interest coverage – –
Current ratio 1.1x 1.3x
Quick ratio 1.1x 1.2x
Cash ratio 0.7x 0.7x
Altman Z-score – –

Shareholder Returns

7 metrics
MetricFEROMAB
Dividend yield 2.6% 5.5%
Net buyback yield – –
Shareholder yield 2.6% 5.5%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusFEROMAB
Forward P/E 46.2xFY2026 14.8xFY2026
EPS, next fiscal year $1.09FY2026 $6.70FY2026
EPS growth, next FY -19.3%FY2026 +4.9%FY2026
EPS growth, the year after +11.0% +29.7%
Revenue, next fiscal year $11.85BFY2026 $941.89MFY2026
Revenue growth, next FY +4.8%FY2026 +2.0%FY2026
Revenue growth, the year after -5.2% +19.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersFEROMAB
Held by institutions 33.2% 12.3%
Institutions holding 337 163
Change in shares held, QoQ +17.5% +5.4%
Institutions buying 208 77
Institutions selling 103 59
Buyers to sellers 2.02 1.31

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

FEROMAB
FER 1.00 0.43
OMAB 0.43 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, FER and OMAB?

Ferrovial (FER) is the largest by market capitalisation: Ferrovial (FER) $36.28B, Central North Airport (OMAB) $4.78B.

Which stock is cheaper, FER and OMAB?

Central North Airport (OMAB) trades on the lowest price-to-earnings ratio (Ferrovial (FER) 36.1x, Central North Airport (OMAB) 16.1x). On next year's consensus earnings, Central North Airport (OMAB) is cheapest (Ferrovial (FER) 46.2x, Central North Airport (OMAB) 14.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which stock has performed better?

Over the past year Central North Airport (OMAB) returned the most: Ferrovial (FER) -21.8%, Central North Airport (OMAB) -3.6%. Over five years, Central North Airport (OMAB) compounded fastest (Ferrovial (FER) +11.4%/yr, Central North Airport (OMAB) +15.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Central North Airport (OMAB) has the highest dividend yield: Ferrovial (FER) 2.57%, Central North Airport (OMAB) 5.47%.

Which stock is riskier?

By one-year price volatility, Ferrovial (FER) has been the steadiest (Ferrovial (FER) 25.4%, Central North Airport (OMAB) 31.2%). Volatility measures how widely the price swings, not the risk of the business.

Do FER and OMAB move together?

Their daily returns over the past year have a correlation of 0.43, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, FER and OMAB?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Central North Airport (OMAB) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.